Network meta-analysis of first-line treatment regimens for HER2-positive advanced gastric cancer
|更新时间:2025-11-10
|
Network meta-analysis of first-line treatment regimens for HER2-positive advanced gastric cancer
“In the field of HER2 positive advanced gastric cancer treatment, researchers found through a network meta-analysis that PemTra_chemo and Per_Tra_chemo regimens have better efficacy, but higher safety risks.”
Network meta-analysis for efficacy and safety of TACE combined with anti-angiogenic drugs in the treatment of unresectable primary liver cancer
Systematic evaluation and network meta-analysis of different cell therapies in the treatment of critical limb ischemia
Network meta-analysis of triple therapy for the prevention and treatment of acute nausea and vomiting caused by emetogenic chemotherapy drugs with moderate and high risk
Pharmacotherapy plan for metastatic hormone-sensitive prostate cancer:a network meta-analysis
Network meta-analysis of the efficacy and safety of different drug regimens in the treatment of children with Kawasaki disease
Related Author
HU Shiping
LU Fenping
WU Fenfang
RAN Yun
ZHAO Kai
LI Xiaobin
LIU Bowen
XING Guangyan
Related Institution
Shenzhen Hospital, Beijing University of Chinese Medicine
Beijing University of Chinese Medicine
Dept. of Nephrology, Shaanxi Sunshine Chinese Medical Hospital for Liver and Kidney Disease
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University